Many neurodegenerative dementias produce significant alterations in the brain that are often not detectable by neurologic tests or with structural imaging. PET is ideally suited for monitoring cell/molecular events early in the course of a disease as well as during pharmacologic therapy. During the past 2 decades, molecular neuroimaging using PET and magnetic resonance (MR) has advanced elegantly and steadily gained importance in the clinical and research arenas. Software- and hardware-based multimodality brain imaging allowing the correlation between anatomic and molecular information has revolutionized clinical diagnosis and now offers unique capabilities for the clinical neuroimaging community and neuroscience researchers at large.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cpet.2010.02.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Anti-inflammatory action of new hybrid -acyl-[1,2]dithiolo-[3,4-]quinoline-1-thione.
SAR QSAR Environ Res
May 2024
InterBioScreen, Chernogolovka, Moscow Region, Russia.
Most of pharmaceutical agents display a number of biological activities. It is obvious that testing even one compound for thousands of biological activities is not practically possible. A computer-aided prediction is therefore the method of choice in this case to select the most promising bioassays for particular compounds.
View Article and Find Full Text PDFLigand-based virtual screening and biological evaluation of inhibitors of H37Rv.
SAR QSAR Environ Res
January 2024
Laboratory of Structure-Function Based Drug Design, Department for Bioinformatics, Institute of Biomedical Chemistry, Moscow, Russia.
Novel antimycobacterial compounds are needed to expand the existing toolbox of therapeutic agents, which sometimes fail to be effective. In our study we extracted, filtered, and aggregated the diverse data on antimycobacterial activity of chemical compounds from the ChEMBL database version 24.1.
View Article and Find Full Text PDFSAR based on self consistent classifier.
SAR QSAR Environ Res
October 2022
Laboratory of Structure-Function Based Drug Design, Department of Bioinformatics, Institute of Biomedical Chemistry, Moscow, Russian Federation.
The accuracy and performance of (Q)SAR models depend significantly on the data used for training. Datasets prepared on the basis of publicly available databases contain structures belonging to different chemical classes and have a highly imbalanced actives/inactives ratio. Currently, hundreds of structural descriptors are used in (Q)SAR studies.
View Article and Find Full Text PDFComputer-aided discovery of pleiotropic effects: Anti-inflammatory action of dithioloquinolinethiones as a case study.
SAR QSAR Environ Res
April 2022
Laboratory of Structure-Function Based Drug Design, Department of Bioinformatics, Institute of Biomedical Chemistry, Moscow, Russia.
Most of pharmaceutical agents exhibit several or even many biological activities. It is clear that testing even one compound for thousands of biological activities is a practically not feasible task. Therefore, computer-aided prediction is the method-of-the-choice to select the most promising bioassays for particular compounds.
View Article and Find Full Text PDFStructure-based classification predicts drug response in EGFR-mutant NSCLC.
Nature
September 2021
Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Epidermal growth factor receptor (EGFR) mutations typically occur in exons 18-21 and are established driver mutations in non-small cell lung cancer (NSCLC). Targeted therapies are approved for patients with 'classical' mutations and a small number of other mutations. However, effective therapies have not been identified for additional EGFR mutations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!